{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:21:49Z","timestamp":1777332109841,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"DST-Inspire","award":["DST\/INSPIRE Fellowship\/09\/IF90083"],"award-info":[{"award-number":["DST\/INSPIRE Fellowship\/09\/IF90083"]}]},{"name":"DBT-NNP","award":["No.BT\/PR40156\/BTIS\/137\/54\/2023"],"award-info":[{"award-number":["No.BT\/PR40156\/BTIS\/137\/54\/2023"]}]},{"name":"DST-FIST","award":["SR\/FST\/LSI-667\/2016"],"award-info":[{"award-number":["SR\/FST\/LSI-667\/2016"]}]},{"name":"DST-PURSE","award":["No. SR\/PURSE Phase 2\/38(G), 2017"],"award-info":[{"award-number":["No. SR\/PURSE Phase 2\/38(G), 2017"]}]},{"name":"MHRD-RUSA","award":["F.24e51\/2014-U"],"award-info":[{"award-number":["F.24e51\/2014-U"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01718-1","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T03:39:47Z","timestamp":1742269187000},"page":"3369-3381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Computational Development of Allosteric Peptide Inhibitors Targeting LIM Kinases as a Novel Therapeutic Intervention"],"prefix":"10.1007","volume":"83","author":[{"given":"Nagarajan","family":"Hemavathy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sampathkumar","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vetrivel","family":"Umashankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeyaraman","family":"Jeyakanthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"1718_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.4155\/fmc.13.216","volume":"6","author":"SW Cowan-Jacob","year":"2014","unstructured":"Cowan-Jacob, S. W., Jahnke, W., & Knapp, S. (2014). Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases. Future Medicinal Chemistry, 6, 541\u2013561. https:\/\/doi.org\/10.4155\/fmc.13.216.","journal-title":"Future Medicinal Chemistry"},{"key":"1718_CR2","doi-asserted-by":"publisher","first-page":"eaan4368","DOI":"10.1126\/science.aan4368","volume":"358","author":"S Klaeger","year":"2017","unstructured":"Klaeger, S., Heinzlmeir, S., Wilhelm, M., Polzer, H., Vick, B., Koenig, P. A., Reinecke, M., Ruprecht, B., Petzoldt, S., Meng, C., Zecha, J., Reiter, K., Qiao, H., Helm, D., Koch, H., Schoof, M., Canevari, G., Casale, E., Depaolini, S. R., & Feuchtinger, A. (2017). The target landscape of clinical kinase drugs. Science, 358, eaan4368. https:\/\/doi.org\/10.1126\/science.aan4368.","journal-title":"Science"},{"key":"1718_CR3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/s41416-018-0045-6","volume":"118","author":"S Knapp","year":"2018","unstructured":"Knapp, S. (2018). New opportunities for kinase drug repurposing and target discovery. British Journal of Cancer, 118, 936\u2013937. https:\/\/doi.org\/10.1038\/s41416-018-0045-6.","journal-title":"British Journal of Cancer"},{"key":"1718_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-030-48283-1_3","volume-title":"Next Generation Kinase Inhibitors","author":"R Martinez","year":"2020","unstructured":"Martinez, R., Defnet, A., & Shapiro, P. (2020). Avoiding or Co-opting ATP inhibition: Overview of type III, IV, V, and VI kinase inhibitors. In P. Shapiro ed, Next Generation Kinase Inhibitors (pp. 29\u201359). Cham: Springer International Publishing."},{"key":"1718_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","volume":"20","author":"MM Attwood","year":"2021","unstructured":"Attwood, M. M., Fabbro, D., Sokolov, A. V., Knapp, S., & Schi\u00f6th, H. B. (2021). Trends in kinase drug discovery: targets, indications and inhibitor design. Nature reviews. Drug discovery, 20, 839\u2013861. https:\/\/doi.org\/10.1038\/s41573-021-00252-y.","journal-title":"Nature reviews. Drug discovery"},{"key":"1718_CR6","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.3390\/ijms25105489","volume":"25","author":"J Li","year":"2024","unstructured":"Li, J., Gong, C., Zhou, H., Liu, J., Xia, X., Ha, W., Jiang, Y., Liu, Q., & Xiong, H. (2024). Kinase inhibitors and kinase-targeted cancer therapies: Recent advances and future perspectives. International Journal of Molecular Sciences, 25, 5489. https:\/\/doi.org\/10.3390\/ijms25105489.","journal-title":"International Journal of Molecular Sciences"},{"key":"1718_CR7","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.tips.2022.04.006","volume":"43","author":"GL Goebel","year":"2022","unstructured":"Goebel, G. L., Qiu, X., & Wu, P. (2022). Kinase-targeting small-molecule inhibitors and emerging bifunctional molecules. Trends in Pharmacological Sciences, 43, 866\u2013881. https:\/\/doi.org\/10.1016\/j.tips.2022.04.006.","journal-title":"Trends in Pharmacological Sciences"},{"key":"1718_CR8","doi-asserted-by":"publisher","first-page":"13264","DOI":"10.1021\/acs.jmedchem.2c01106","volume":"65","author":"T Hanke","year":"2022","unstructured":"Hanke, T., Mathea, S., Woortman, J., Salah, E., Berger, B. T., Tumber, A., Kashima, R., Hata, A., Kuster, B., M\u00fcller, S., & Knapp, S. (2022). Development and characterization of Type I, Type II, and Type III LIM-kinase chemical probes. Journal of Medicinal Chemistry, 65, 13264\u201313287. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01106.","journal-title":"Journal of Medicinal Chemistry"},{"key":"1718_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1021\/ml500242y","volume":"6","author":"NC Goodwin","year":"2015","unstructured":"Goodwin, N. C., Cianchetta, G., Burgoon, H. A., Healy, J., Mabon, R., Strobel, E. D., Allen, J., Wang, S., Hamman, B. D., & Rawlins, D. B. (2015). Discovery of a Type III inhibitor of LIM kinase 2 that binds in a DFG-out conformation. ACS Medicinal Chemistry Letters, 6, 53\u201357. https:\/\/doi.org\/10.1021\/ml500242y.","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"1718_CR10","doi-asserted-by":"publisher","first-page":"38469","DOI":"10.18632\/oncotarget.6288","volume":"6","author":"K Mardilovich","year":"2015","unstructured":"Mardilovich, K., Baugh, M., Crighton, D., Kowalczyk, D., Gabrielsen, M., Munro, J., Croft, D. R., Lourenco, F., James, D., Kalna, G., McGarry, L., Rath, O., Shanks, E., Garnett, M. J., McDermott, U., Brookfield, J., Charles, M., Hammonds, T., & Olson, M. F. (2015). LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation. Oncotarget, 6, 38469\u201338486. https:\/\/doi.org\/10.18632\/oncotarget.6288.","journal-title":"Oncotarget"},{"key":"1718_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/cells11010142","volume":"11","author":"D Chatterjee","year":"2022","unstructured":"Chatterjee, D., Preuss, F., Dederer, V., Knapp, S., & Mathea, S. (2022). Structural aspects of LIMK regulation and pharmacology. Cells, 11, 142. https:\/\/doi.org\/10.3390\/cells11010142.","journal-title":"Cells"},{"key":"1718_CR12","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1042\/BCJ20190517","volume":"476","author":"E Salah","year":"2019","unstructured":"Salah, E., Chatterjee, D., Beltrami, A., Tumber, A., Preuss, F., Canning, P., Chaikuad, A., Knaus, P., Knapp, S., Bullock, A. N., & Mathea, S. (2019). Lessons from LIMK1 enzymology and their impact on inhibitor design. The Biochemical Journal, 476, 3197\u20133209. https:\/\/doi.org\/10.1042\/BCJ20190517.","journal-title":"The Biochemical Journal"},{"key":"1718_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ejmech.2018.06.016","volume":"155","author":"F Manetti","year":"2018","unstructured":"Manetti, F. (2018). Recent advances in the rational design and development of LIM kinase inhibitors are not enough to enter clinical trials. European Journal of Medicinal Chemistry, 155, 445\u2013458. https:\/\/doi.org\/10.1016\/j.ejmech.2018.06.016.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"1718_CR14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.biocel.2006.11.011","volume":"39","author":"O Bernard","year":"2007","unstructured":"Bernard, O. (2007). Lim kinases, regulators of actin dynamics. The International Journal of Biochemistry & Cell Biology, 39, 1071\u20131076. https:\/\/doi.org\/10.1016\/j.biocel.2006.11.011.","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"1718_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1042\/0264-6021:3540149","volume":"354","author":"T Amano","year":"2001","unstructured":"Amano, T., Tanabe, K., Eto, T., Narumiya, S., & Mizuno, K. (2001). LIM-kinase 2 induces formation of stress fibres, focal adhesions and membrane blebs, dependent on its activation by Rho-associated kinase-catalysed phosphorylation at threonine-505. The Biochemical Journal, 354, 149\u2013159. https:\/\/doi.org\/10.1042\/0264-6021:3540149.","journal-title":"The Biochemical Journal"},{"key":"1718_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/cells12050805","volume":"12","author":"E Villalonga","year":"2023","unstructured":"Villalonga, E., Mosrin, C., Normand, T., Girardin, C., Serrano, A., \u017dunar, B., Doudeau, M., Godin, F., B\u00e9n\u00e9detti, H., & Vall\u00e9e, B. (2023). LIM kinases, LIMK1 and LIMK2, are crucial node actors of the cell fate: Molecular to pathological features. Cells, 12, 805. https:\/\/doi.org\/10.3390\/cells12050805.","journal-title":"Cells"},{"key":"1718_CR17","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0962-8924(02)02404-2","volume":"12","author":"JR Bamburg","year":"2002","unstructured":"Bamburg, J. R., & Wiggan, O. P. (2002). ADF\/cofilin and actin dynamics in disease. Trends in Cell Biology, 12, 598\u2013605. https:\/\/doi.org\/10.1016\/S0962-8924(02)02404-2.","journal-title":"Trends in Cell Biology"},{"key":"1718_CR18","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/31729","volume":"393","author":"S Arber","year":"1998","unstructured":"Arber, S., Barbayannis, F. A., Hanser, H., Schneider, C., Stanyon, C. A., Bernard, O., & Caroni, P. (1998). Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature, 393, 805\u2013809. https:\/\/doi.org\/10.1038\/31729.","journal-title":"Nature"},{"key":"1718_CR19","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3390\/cells11132090","volume":"11","author":"R Berabez","year":"2022","unstructured":"Berabez, R., Routier, S., B\u00e9n\u00e9detti, H., Pl\u00e9, K., & Vall\u00e9e, B. (2022). LIM kinases, promising but reluctant therapeutic targets: Chemistry and preclinical validation in vivo. Cells, 11, 2090. https:\/\/doi.org\/10.3390\/cells11132090.","journal-title":"Cells"},{"key":"1718_CR20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/sj.emboj.7600973","volume":"25","author":"M Kobayashi","year":"2006","unstructured":"Kobayashi, M., Nishita, M., Mishima, T., Ohashi, K., & Mizuno, K. (2006). MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. The EMBO Journal, 25, 713\u2013726. https:\/\/doi.org\/10.1038\/sj.emboj.7600973.","journal-title":"The EMBO Journal"},{"key":"1718_CR21","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1073\/pnas.1232344100","volume":"100","author":"K Yoshioka","year":"2003","unstructured":"Yoshioka, K., Foletta, V., Bernard, O., & Itoh, K. (2003). A role for LIM kinase in cancer invasion. Proceedings of the National Academy of Sciences of the United States of America, 100, 7247\u20137252. https:\/\/doi.org\/10.1073\/pnas.1232344100.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"1718_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1349-7006.2005.00062.x","volume":"96","author":"D Yamazaki","year":"2005","unstructured":"Yamazaki, D., Kurisu, S., & Takenawa, T. (2005). Regulation of cancer cell motility through actin reorganization. Cancer Science, 96, 379\u2013386. https:\/\/doi.org\/10.1111\/j.1349-7006.2005.00062.x.","journal-title":"Cancer Science"},{"key":"1718_CR23","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.bbamcr.2006.07.001","volume":"1773","author":"H Yamaguchi","year":"2007","unstructured":"Yamaguchi, H., & Condeelis, J. (2007). Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochimica et Biophysica Acta, 1773, 642\u2013652. https:\/\/doi.org\/10.1016\/j.bbamcr.2006.07.001.","journal-title":"Biochimica et Biophysica Acta"},{"key":"1718_CR24","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1038\/sj.emboj.7600418","volume":"23","author":"ST Lee-Hoeflich","year":"2004","unstructured":"Lee-Hoeflich, S. T., Causing, C. G., Podkowa, M., Zhao, X., Wrana, J. L., & Attisano, L. (2004). Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. The EMBO Journal, 23, 4792\u20134801. https:\/\/doi.org\/10.1038\/sj.emboj.7600418.","journal-title":"The EMBO Journal"},{"key":"1718_CR25","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1091\/mbc.e13-09-0540","volume":"25","author":"K Ohashi","year":"2014","unstructured":"Ohashi, K., Sampei, K., Nakagawa, M., Uchiumi, N., Amanuma, T., Aiba, S., Oikawa, M., & Mizuno, K. (2014). Damnacanthal, an effective inhibitor of LIM-kinase, inhibits cell migration and invasion. Molecular Biology of the Cell, 25, 828\u2013840. https:\/\/doi.org\/10.1091\/mbc.e13-09-0540.","journal-title":"Molecular Biology of the Cell"},{"key":"1718_CR26","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/0008-5472.CAN-11-3342","volume":"72","author":"R Prudent","year":"2012","unstructured":"Prudent, R., Vassal-Stermann, E., Nguyen, C.-H., Pillet, C., Martinez, A., Prunier, C., Barette, C., Soleilhac, E., Filhol, O., Beghin, A., Valdameri, G., Honor\u00e9, S., Aci-S\u00e8che, S., Grierson, D., Antonipillai, J., Li, R., Di Pietro, A., Dumontet, C., Braguer, D., & Lafanech\u00e8re, L. (2012). Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growth. Cancer Research, 72, 4429\u20134439. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3342.","journal-title":"Cancer Research"},{"key":"1718_CR27","doi-asserted-by":"publisher","first-page":"41749","DOI":"10.18632\/oncotarget.16978","volume":"8","author":"C Prunier","year":"2017","unstructured":"Prunier, C., Prudent, R., Kapur, R., Sadoul, K., & Lafanech\u00e8re, L. (2017). LIM kinases: cofilin and beyond. Oncotarget, 8, 41749\u201341763. https:\/\/doi.org\/10.18632\/oncotarget.16978.","journal-title":"Oncotarget"},{"key":"1718_CR28","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.1016\/j.bmcl.2011.07.050","volume":"21","author":"BE Sleebs","year":"2011","unstructured":"Sleebs, B. E., Nikolakopoulos, G., Street, I. P., Falk, H., & Baell, J. B. (2011). Identification of 5,6-substituted 4-aminothieno2,3-dpyrimidines as LIMK1 inhibitors. Bioorganic & Medicinal Chemistry Letters, 21, 5992\u20135994. https:\/\/doi.org\/10.1016\/j.bmcl.2011.07.050.","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"1718_CR29","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s12276-023-01016-x","volume":"55","author":"SMP Vadevoo","year":"2023","unstructured":"Vadevoo, S. M. P., Gurung, S., Lee, H.-S., Gunassekaran, G. R., Lee, S. M., Yoon, J. W., Lee, Y. K., & Lee, B. (2023). Peptides as multifunctional players in cancer therapy. Experimental & Molecular Medicine, 55, 1099\u20131109. https:\/\/doi.org\/10.1038\/s12276-023-01016-x.","journal-title":"Experimental & Molecular Medicine"},{"key":"1718_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022). Therapeutic peptides: current applications and future directions. Signal Transduction and Targeted Therapy, 7, 48. https:\/\/doi.org\/10.1038\/s41392-022-00904-4.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"1718_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbapap.2005.07.025","volume":"1754","author":"MA Bogoyevitch","year":"2005","unstructured":"Bogoyevitch, M. A., Barr, R. K., & Ketterman, A. J. (2005). Peptide inhibitors of protein kinases-discovery, characterisation and use. Biochimica et Biophysica Acta, 1754, 79\u201399. https:\/\/doi.org\/10.1016\/j.bbapap.2005.07.025.","journal-title":"Biochimica et Biophysica Acta"},{"key":"1718_CR32","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/cbic.201300253","volume":"14","author":"VM Bharathikumar","year":"2013","unstructured":"Bharathikumar, V. M., Barreto, K., Decoteau, J. F., & Geyer, C. R. (2013). Allosteric lariat peptide inhibitors of Abl kinase. Chembiochem, 14, 2119\u20132125. https:\/\/doi.org\/10.1002\/cbic.201300253.","journal-title":"Chembiochem"},{"key":"1718_CR33","doi-asserted-by":"publisher","first-page":"13130","DOI":"10.1039\/D4SC01088D","volume":"15","author":"B Biswas","year":"2024","unstructured":"Biswas, B., Huang, Y.-H., Craik, D. J., & Wang, C. K. (2024). The prospect of substrate-based kinase inhibitors to improve target selectivity and overcome drug resistance. Chemical Science, 15, 13130\u201313147. https:\/\/doi.org\/10.1039\/D4SC01088D.","journal-title":"Chemical Science"},{"key":"1718_CR34","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.2174\/092986712801661004","volume":"19","author":"RJ Boohaker","year":"2012","unstructured":"Boohaker, R. J., Lee, M. W., Vishnubhotla, P., Perez, J. M., & Khaled, A. R. (2012). The use of therapeutic peptides to target and to kill cancer cells. Current Medicinal Chemistry, 19, 3794\u20133804. https:\/\/doi.org\/10.2174\/092986712801661004.","journal-title":"Current Medicinal Chemistry"},{"key":"1718_CR35","doi-asserted-by":"publisher","unstructured":"Ciulla, M. G., Civera, M., Sattin, S., Kumar, K. (2023). Nature-inspired and medicinally relevant short peptides. Exploration of Drug Science, 140\u2013171. https:\/\/doi.org\/10.37349\/eds.2023.00011.","DOI":"10.37349\/eds.2023.00011"},{"key":"1718_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02553-7","volume":"22","author":"R Naeimi","year":"2022","unstructured":"Naeimi, R., Bahmani, A., & Afshar, S. (2022). Investigating the role of peptides in effective therapies against cancer. Cancer Cell International, 22, 139 https:\/\/doi.org\/10.1186\/s12935-022-02553-7.","journal-title":"Cancer Cell International"},{"key":"1718_CR37","doi-asserted-by":"crossref","unstructured":"Lee, H., Yosaatmadja, Y., Burgess-Brown, N. A., von Delft, F., Arrowsmith, C. H., Edwards, A., Bountra, C., Elkins, J. M. (2022). Structure of LIMK1 kinase domain with allosteric inhibitor TH-470.","DOI":"10.2210\/pdb7b8w\/pdb"},{"key":"1718_CR38","doi-asserted-by":"crossref","unstructured":"Mathea, S., Salah, E., Hanke, T., & Knapp, S. (2021). LIM domain kinase 2 (LIMK2) in complex with TH-470.","DOI":"10.2210\/pdb7qhg\/pdb"},{"key":"1718_CR39","doi-asserted-by":"publisher","first-page":"Unit-5.6","DOI":"10.1002\/0471250953.bi0506s15","volume":"Chapter 5","author":"N Eswar","year":"2006","unstructured":"Eswar, N., Webb, B., Marti-Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M. Y., Pieper, U., & Sali, A. (2006). Chapter 5, 5 Comparative protein structure modeling using Modeller. Current Protocols in Bioinformatics, Chapter 5, Unit-5.6. https:\/\/doi.org\/10.1002\/0471250953.bi0506s15.","journal-title":"Current Protocols in Bioinformatics"},{"key":"1718_CR40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/07391102.2013.770373","volume":"32","author":"A Kumar","year":"2014","unstructured":"Kumar, A., Rajendran, V., Sethumadhavan, R., & Purohit, R. (2014). Relationship between a point mutation S97C in CK1\u03b4 protein and its affect on ATP-binding affinity. Journal of Biomolecular Structure & Dynamics, 32, 394\u2013405. https:\/\/doi.org\/10.1080\/07391102.2013.770373.","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"key":"1718_CR41","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F., & Forli, S. (2021). AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. Journal of Chemical Information And Modeling, 61, 3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203.","journal-title":"Journal of Chemical Information And Modeling"},{"key":"1718_CR42","doi-asserted-by":"publisher","unstructured":"Bauer, P., Hess, B., Lindahl, E. (2022). GROMACS 2022.1 Manual. https:\/\/doi.org\/10.5281\/zenodo.6451567.","DOI":"10.5281\/zenodo.6451567"},{"key":"1718_CR43","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1111\/cbdd.13607","volume":"94","author":"S Ansar","year":"2019","unstructured":"Ansar, S., & Vetrivel, U. (2019). PepVis: An integrated peptide virtual screening pipeline for ensemble and flexible docking protocols. Chemical Biology & Drug Design, 94, 2041\u20132050. https:\/\/doi.org\/10.1111\/cbdd.13607.","journal-title":"Chemical Biology & Drug Design"},{"key":"1718_CR44","doi-asserted-by":"publisher","first-page":"e4442","DOI":"10.1002\/pro.4442","volume":"31","author":"CHM Rodrigues","year":"2022","unstructured":"Rodrigues, C. H. M., Garg, A., Keizer, D., Pires, D., & Ascher, D. B. (2022). CSM-peptides: A computational approach to rapid identification of therapeutic peptides. Protein Science, 31, e4442. https:\/\/doi.org\/10.1002\/pro.4442.","journal-title":"Protein Science"},{"key":"1718_CR45","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1093\/bioinformatics\/btac006","volume":"38","author":"L Wei","year":"2022","unstructured":"Wei, L., Ye, X., Sakurai, T., Mu, Z., & Wei, L. (2022). ToxIBTL: prediction of peptide toxicity based on information bottleneck and transfer learning. Bioinformatics, 38, 1514\u20131524. https:\/\/doi.org\/10.1093\/bioinformatics\/btac006.","journal-title":"Bioinformatics"},{"key":"1718_CR46","doi-asserted-by":"publisher","first-page":"108926","DOI":"10.1016\/j.compbiomed.2024.108926","volume":"179","author":"AS Rathore","year":"2024","unstructured":"Rathore, A. S., Choudhury, S., Arora, A., Tijare, P., & Raghava, G. (2024). ToxinPred 3.0: An improved method for predicting the toxicity of peptides. Computers in Biology and Medicine, 179, 108926. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108926.","journal-title":"Computers in Biology and Medicine"},{"key":"1718_CR47","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/nar\/gkv315","volume":"43","author":"S Salentin","year":"2015","unstructured":"Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F., & Schroeder, M. (2015). PLIP: fully automated protein-ligand interaction profiler. Nucleic Acids Research, 43, W443\u2013W447. https:\/\/doi.org\/10.1093\/nar\/gkv315.","journal-title":"Nucleic Acids Research"},{"key":"1718_CR48","doi-asserted-by":"publisher","first-page":"W322","DOI":"10.1093\/nar\/gkz397","volume":"47","author":"G Weng","year":"2019","unstructured":"Weng, G., Wang, E., Wang, Z., Liu, H., Zhu, F., Li, D., & Hou, T. (2019). HawkDock: a web server to predict and analyze the protein-protein complex based on computational docking and MM\/GBSA. Nucleic Acids Research, 47, W322\u2013W330. https:\/\/doi.org\/10.1093\/nar\/gkz397.","journal-title":"Nucleic Acids Research"},{"key":"1718_CR49","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco, M. S., Vald\u00e9s-Tresanco, M. E., Valiente, P. A., & Moreno, E. (2021). gmx_MMPBSA: A new tool to perform end-state free energy calculations with GROMACS. Journal of Chemical Theory And Computation, 17, 6281\u20136291. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645.","journal-title":"Journal of Chemical Theory And Computation"},{"key":"1718_CR50","doi-asserted-by":"publisher","first-page":"9424","DOI":"10.1080\/07391102.2022.2141895","volume":"41","author":"B Sharma","year":"2023","unstructured":"Sharma, B., Bhattacherjee, D., Zyryanov, G. V., & Purohit, R. (2023). An insight from computational approach to explore novel, high-affinity phosphodiesterase 10A inhibitors for neurological disorders. Journal of Biomolecular Structure & Dynamics, 41, 9424\u20139436. https:\/\/doi.org\/10.1080\/07391102.2022.2141895.","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"key":"1718_CR51","doi-asserted-by":"publisher","first-page":"107367","DOI":"10.1016\/j.cmpb.2023.107367","volume":"231","author":"R Singh","year":"2023","unstructured":"Singh, R., & Purohit, R. (2023). Computational analysis of protein-ligand interaction by targeting a cell cycle restrainer. Computer Methods and Programs in Biomedicine, 231, 107367. https:\/\/doi.org\/10.1016\/j.cmpb.2023.107367.","journal-title":"Computer Methods and Programs in Biomedicine"},{"key":"1718_CR52","doi-asserted-by":"publisher","first-page":"110094","DOI":"10.1016\/j.jtbi.2019.110094","volume":"486","author":"V Bhardwaj","year":"2020","unstructured":"Bhardwaj, V., Singh, R., Singh, P., Purohit, R., & Kumar, S. (2020). Elimination of bitter-off taste of stevioside through structure modification and computational interventions. Journal of Theoretical Biology, 486, 110094. https:\/\/doi.org\/10.1016\/j.jtbi.2019.110094.","journal-title":"Journal of Theoretical Biology"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01718-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01718-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01718-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T08:21:41Z","timestamp":1757146901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01718-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1718"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01718-1","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"2 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}